Preprint · OA
via OpenAlex
MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo
Tilde Veng Eskildsen, Hanna Taipaleenmäki, Jan Stenvang, Basem M. Abdallah, Nicholas Ditzel, Anne Yaël Nossent, Mads Bak, Sakari Kauppinen, Moustapha S Kassem
Proceedings of the National Academy of Sciences · 2011 · ▲ 496 citations
Abstract
Elucidating the molecular mechanisms that regulate human stromal (mesenchymal) stem cell (hMSC) differentiation into osteogenic lineage is important for the development of anabolic therapies for treatment of osteoporosis. MicroRNAs (miRNAs) are short, noncoding RNAs that act as key regulators of diverse biological processes by mediating translational repression or mRNA degradation of their target genes. Here, we show that miRNA-138 (miR-138) modulates osteogenic differentiation of hMSCs. miRNA array profiling and further validation by quantitative RT-PCR (qRT-PCR) revealed that miR-138 was down-regulated during osteoblast differentiation of hMSCs. Overexpression of miR-138 inhibited osteoblast differentiation of hMSCs in vitro, whereas inhibition of miR-138 function by antimiR-138 promoted expression of osteoblast-specific genes, alkaline phosphatase (ALP) activity, and matrix mineralization. Furthermore, overexpression of miR-138 reduced ectopic bone formation in vivo by 85%, and conversely, in vivo bone formation was enhanced by 60% when miR-138 was antagonized. Target prediction analysis and experimental validation by luciferase 3' UTR reporter assay confirmed focal adhesion kinase, a kinase playing a central role in promoting osteoblast differentiation, as a bona fide target of miR-138. We show that miR-138 attenuates bone formation in vivo, at least in part by inhibiting the focal adhesion kinase signaling pathway. Our findings suggest that pharmacological inhibition of miR-138 by antimiR-138 could represent a therapeutic strategy for enhancing bone formation in vivo.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1073/pnas.1016758108
- Canonical
- link ↗
- Fetched
- 2026-09-28 MST
Cite this
APA
Eskildsen, T.V., Taipaleenmäki, H., Stenvang, J., Abdallah, B.M., Ditzel, N., Nossent, A.Y., Bak, M., Kauppinen, S., & Kassem, M.S. (2011). MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. <em>Proceedings of the National Academy of Sciences</em>. https://doi.org/10.1073/pnas.1016758108
Vancouver
Eskildsen TV, Taipaleenmäki H, Stenvang J, Abdallah BM, Ditzel N, Nossent AY, et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proceedings of the National Academy of Sciences. 2011. doi:10.1073/pnas.1016758108.
BibTeX
@unpublished{tilde2011MicroR,
title = {MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo},
author = {Tilde Veng Eskildsen and Hanna Taipaleenmäki and Jan Stenvang and Basem M. Abdallah and Nicholas Ditzel and Anne Yaël Nossent and Mads Bak and Sakari Kauppinen and Moustapha S Kassem},
journal = {Proceedings of the National Academy of Sciences},
year = {2011},
doi = {10.1073/pnas.1016758108},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biomolecules 2025
Open access · CC-BY
Rejuvenation of Bone Marrow Mesenchymal Stem Cells: Mechanisms and Their Application in Senile Osteoporosis Treatment
Theranostics 2026
Open access · CC-BY
ARG2 drives osteoblast senescence by repressing mitophagy via the IκB–NF-κB–TXN2 signaling axis: implications for age-associated osteoporosis
Open Scholarship Institutional Repository (Washington University in St. Louis) 2019
Preprint · OA
Molecular Regulation of Vertebrate Pigmentation and Stem Cell Quiescence in Larval Zebrafish
Stem Cell Research & Therapy 2018
Open access · CC-BY
Osteogenesis and aging: lessons from mesenchymal stem cells
Cell Death and Disease 2026
Open access · CC-BY
Taurine transporter SLC6A6 expression promotes mesenchymal stromal cell function
Bone 2027
Citation only